Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rechallenge Using Combined Partial Tumor Irradiation and Immune Checkpoint Inhibitor-based Immunotherapy for Unresectable Lung Adenocarcinoma: a Pilot Study

NCT07423169 is registered in ClinicalTrials.gov with Karl Landsteiner University of Health Sciences as lead sponsor.

NCT NCT07423169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07423169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rechallenge Using Combined Partial Tumor Irradiation and Immune Checkpoint Inhibitor-based Immunotherapy for Unresectable Lung Adenocarcinoma: a Pilot Study
Lead sponsor
Karl Landsteiner University of Health Sciences
Phase
Not applicable
Overall status
Recruiting
Start date
February 2, 2026
Completion date
February 29, 2028
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bulky tumors, lung adenocarcinoma, unresectable cancer